View in EDS

LBA51 Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

Saved in:
Bibliographic Details
Title: LBA51 Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.
Authors: Masip, J. Remon1 (AUTHOR), Besse, B.1 (AUTHOR), Aix, S. Ponce2 (AUTHOR), Callejo, A.3 (AUTHOR), Al-Rabi, K.4 (AUTHOR), Caro, R. Bernabe5 (AUTHOR), Greillier, L.6 (AUTHOR), Tarruella, M. Majem7 (AUTHOR), Aransay, N. Reguart8 (AUTHOR), Monnet, I.9 (AUTHOR), Cousin, S.10 (AUTHOR), Lopez, P. Garrido11 (AUTHOR), Robinet, G.12 (AUTHOR), Campelo, M.R. Garcia13 (AUTHOR), Flandin, A-C. Madroszyk14 (AUTHOR), Mazieres, J.15 (AUTHOR), Pretzenbacher, Y.16 (AUTHOR), Fournier, B.17 (AUTHOR), Dingemans, A-M.C.18 (AUTHOR), Dziadziuszko, R.19 (AUTHOR)
Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1419-S1419. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 159078754
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: LBA51 Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Masip%2C+J%2E+Remon%22">Masip, J. Remon</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Besse%2C+B%2E%22">Besse, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aix%2C+S%2E+Ponce%22">Aix, S. Ponce</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Callejo%2C+A%2E%22">Callejo, A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Rabi%2C+K%2E%22">Al-Rabi, K.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Caro%2C+R%2E+Bernabe%22">Caro, R. Bernabe</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Greillier%2C+L%2E%22">Greillier, L.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tarruella%2C+M%2E+Majem%22">Tarruella, M. Majem</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aransay%2C+N%2E+Reguart%22">Aransay, N. Reguart</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Monnet%2C+I%2E%22">Monnet, I.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cousin%2C+S%2E%22">Cousin, S.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lopez%2C+P%2E+Garrido%22">Lopez, P. Garrido</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Robinet%2C+G%2E%22">Robinet, G.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Campelo%2C+M%2ER%2E+Garcia%22">Campelo, M.R. Garcia</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Flandin%2C+A-C%2E+Madroszyk%22">Flandin, A-C. Madroszyk</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mazieres%2C+J%2E%22">Mazieres, J.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pretzenbacher%2C+Y%2E%22">Pretzenbacher, Y.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fournier%2C+B%2E%22">Fournier, B.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dingemans%2C+A-M%2EC%2E%22">Dingemans, A-M.C.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dziadziuszko%2C+R%2E%22">Dziadziuszko, R.</searchLink><relatesTo>19</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS1419-S1419. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159078754
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2022.08.053
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S1419
    Titles:
      – TitleFull: LBA51 Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Masip, J. Remon
      – PersonEntity:
          Name:
            NameFull: Besse, B.
      – PersonEntity:
          Name:
            NameFull: Aix, S. Ponce
      – PersonEntity:
          Name:
            NameFull: Callejo, A.
      – PersonEntity:
          Name:
            NameFull: Al-Rabi, K.
      – PersonEntity:
          Name:
            NameFull: Caro, R. Bernabe
      – PersonEntity:
          Name:
            NameFull: Greillier, L.
      – PersonEntity:
          Name:
            NameFull: Tarruella, M. Majem
      – PersonEntity:
          Name:
            NameFull: Aransay, N. Reguart
      – PersonEntity:
          Name:
            NameFull: Monnet, I.
      – PersonEntity:
          Name:
            NameFull: Cousin, S.
      – PersonEntity:
          Name:
            NameFull: Lopez, P. Garrido
      – PersonEntity:
          Name:
            NameFull: Robinet, G.
      – PersonEntity:
          Name:
            NameFull: Campelo, M.R. Garcia
      – PersonEntity:
          Name:
            NameFull: Flandin, A-C. Madroszyk
      – PersonEntity:
          Name:
            NameFull: Mazieres, J.
      – PersonEntity:
          Name:
            NameFull: Pretzenbacher, Y.
      – PersonEntity:
          Name:
            NameFull: Fournier, B.
      – PersonEntity:
          Name:
            NameFull: Dingemans, A-M.C.
      – PersonEntity:
          Name:
            NameFull: Dziadziuszko, R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2022 Supplement 7
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 33
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1